Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | DRNA | IDYA | IMCR | ||
Company | Dicerna Pharmaceutic | Ideaya Biosciences Inc | Immunocore Holdings Plc ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 38.21 | 39.98 | 58.58 | ||
High | 38.24 | 41.38 | 60.02 | ||
Low | 38.21 | 39.98 | 57.60 | ||
Last | 38.22 | 40.65 | 58.10 | ||
Change | +0.22 | +0.71 | -0.36 | ||
% Change | +0.58% | +1.78% | -0.62% | ||
Volume | 5,568,900 | 636,100 | 538,400 | ||
20-Day Average Volume | 3,647,665 | 594,695 | 441,970 | ||
Previous Close | 38.00 | 39.94 | 58.46 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 38.03 | 40.66 | 58.30 | ||
20-Day Raw Stochastic | 90.72% | 56.10% | 48.34% | ||
20-Day Relative Strength | 80.40% | 47.68% | 44.41% | ||
Weighted Alpha | +35.17 | +96.69 | -4.22 | ||
Today's Opinion | 88% Buy | 8% Buy | 56% Sell | ||
Previous Opinion | 72% Buy | 24% Buy | 56% Sell | ||
Last Month's Opinion | 24% Buy | 56% Buy | 40% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +1.08% since 12/17/21 | +8.14% since 04/22/24 | +4.08% since 04/22/24 | ||
Low | 37.81 on 12/21/21 | 37.81 on 04/25/24 | 55.92 on 04/24/24 | ||
High | 38.24 on 12/27/21 | 41.38 on 04/29/24 | 60.02 on 04/29/24 | ||
1-Month | |||||
%Chg | +0.61% since 11/26/21 | -7.36% since 03/28/24 | -10.62% since 03/28/24 | ||
Low | 37.78 on 12/10/21 | 36.58 on 04/19/24 | 52.14 on 04/17/24 | ||
High | 38.26 on 12/03/21 | 44.25 on 04/01/24 | 66.00 on 04/01/24 | ||
3-Month | |||||
%Chg | +83.31% since 09/27/21 | -8.07% since 01/29/24 | -19.42% since 01/29/24 | ||
Low | 19.06 on 10/06/21 | 36.58 on 04/19/24 | 52.14 on 04/17/24 | ||
High | 38.26 on 12/03/21 | 47.74 on 02/15/24 | 76.98 on 02/01/24 | ||
6-Month | |||||
%Chg | +1.95% since 06/25/21 | +58.98% since 10/27/23 | +35.59% since 10/27/23 | ||
Low | 19.06 on 10/06/21 | 25.22 on 10/30/23 | 42.21 on 10/30/23 | ||
High | 40.14 on 07/20/21 | 47.74 on 02/15/24 | 76.98 on 02/01/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 2,986,090 | 2,986,114 | 2,912,535 | ||
Shares Outstanding, K | 78,129 | 74,765 | 49,821 | ||
Annual Sales | 164,310,000 | 23,390,000 | 249,430,000 | ||
Annual Net Income | -112,750,000 | -112,960,000 | -55,290,000 | ||
Last Quarter Sales | 62,950,000 | 3,920,000 | 70,340,000 | ||
Last Quarter Net Income | -17,070,000 | -33,950,000 | -19,790,000 | ||
60-Month Beta | 0.80 | 0.80 | 0.89 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A on 11/09/21 | -0.52 on 02/20/24 | -0.40 on 02/28/24 | ||
Latest Earnings Date | 11/09/21 | 05/14/24 | 05/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |